SRTD Biotech €31.5M Seed round led by Mérieux Equity Partners (Mérieux Innovation 2 fund) Seva Money €4.5M Seed round led by Revent Crowd Threat €1.2M raises a funding round Memora €1.8M (DKK 13M) funding round led by True Collective Marble Imaging €6M Seed round led by Cherry Ventures Onodrim Industries €268.7M ($300M) Series A round led by Lux Capital Vensum Power €9M Series A round led by Lifeline Ventures Alethio Therapeutics €80.3M Series A round led by Sofinnova Partners T-Therapeutics €118.4M ($133M) Series B round led by Advent Life Sciences Granit €3.5M funding round led by Seedcamp Mindmax €3.0M ($3.3M) Pre-seed round led by Concept Ventures FluoRok €26.7M ($30M) Series A round led by Orano Venture Fund Kabilio €10M funding round led by Picus Capital Claimlane €5.6M Series A round led by Verb Ventures Green Voltis €13.5M Series A round led by Lochpine Capital VÆRIDION €30M Series A round led by SHIFT Invest Conlio €6.4M funding round led by Piton Capital 1nhaler €2.7M (£2.2M) funding round led by Archangels Vitroscope €4.5M ($5M) Seed round led by Cerberus Ventures Granter €1.6M funding round led by 3XP Global (via its Impact Innovation Fund

Sesame Summit 2027

M

Mérieux Equity Partners

● Actively deploying

Pitch this fund

Investment thesis

Sesamers tracks 2 portfolio companies across 2 rounds, 2 of them as lead investor. Its most recent tracked deal: SRTD Biotech, Nov 2026.

Portfolio

SB SRTD Biotech Seed · 2026 · Led H HighLife Growth · 2026 · Led · Paris, France

Past investments

Company	Round	Role	Date	Round size
SRTD Biotech Read the announcement →	Seed	Lead	Nov 2026	€31.5M
HighLife Paris, France Read the announcement →	Growth	Lead	Sep 2026	€80M

Sesamers coverage

November 10, 2026

SRTD Biotech raises €31.5M seed for cell-selective mRNA

September 25, 2026

HighLife raises $90M+ to start US pivotal study for its mitral valve

Get the weekly briefing Europe's rounds, founders & events - every Monday, in five minutes.